VOYAGER: an International Consortium Investigating the Role of Human Papilloma Virus and Genetics in Oral and Oropharyngeal Cancer Risk and Survival

Overview

Journal medRxiv

Date 2025 Mar 4

PMID 40034767

Authors

M Gormley

A Adhikari

T Dudding

M Pring

K Hurley

G J Macfarlane

P Lagiou

A Lagiou

J Polesel

A Agudo

L Alemany

W Ahrens

C M Healy

D I Conway

C Canova

I Holcatova

L Richiardi

A Znaor

A F Olshan

R J Hung

G Liu

S Bratman

X Zhao

J Holt

R Cortez

V Gaborieau

J D McKay

T Waterboer

P Brennan

N Hayes

B Diergaarde

S Virani

Affiliations

Soon will be listed here.

Abstract

Head and neck cancer (HNC) is the sixth most common cancer globally. Incidence and survival rates vary significantly across geographic regions and tumor subsites. This is partly due to differences in risk factor exposure, which includes tobacco smoking, alcohol consumption and human papillomavirus (HPV) infection, alongside detection and treatment strategies. The VOYAGER (human papillomaVirus, Oral and oropharYngeal cAncer GEnomic Research) consortium is a collaboration between five large North American and European studies which generated data on 10,530 participants (7,233 cases and 3,297 controls). The primary goal of the collaboration was to improve understing of the role of HPV and genetic factors in oral cavity and oropharyngeal cancer risk and outcome. Demographic and clinical data collected by the five studies were harmonized, and HPV status was determined for the majority of cases. In addition, 999 tumors were sequenced to define somatic mutations. These activities generated a comprehensive biomedical resource that can be utilized to answer critical outsting research questions to help improve HNC prevention, early detection, treatment, and surveillance.

References

Waterboer T, Sehr P, Pawlita M . Suppression of non-specific binding in serological Luminex assays. J Immunol Methods. 2006; 309(1-2):200-4. DOI: 10.1016/j.jim.2005.11.008. View

. Post-Treatment Head and Neck Cancer Care: National Audit and Analysis of Current Practice in the United Kingdom. Clin Otolaryngol. 2020; 46(1):284-294. DOI: 10.1111/coa.13616. View

Zhao X, Wang A, Walter V, Patel N, Eberhard D, Hayward M . Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLC. PLoS One. 2015; 10(6):e0129280. PMC: 4468211. DOI: 10.1371/journal.pone.0129280. View

Scheffner M, Werness B, Huibregtse J, Levine A, Howley P . The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell. 1990; 63(6):1129-36. DOI: 10.1016/0092-8674(90)90409-8. View

Pickering C, Zhang J, Neskey D, Zhao M, Jasser S, Wang J . Squamous cell carcinoma of the oral tongue in young non-smokers is genomically similar to tumors in older smokers. Clin Cancer Res. 2014; 20(14):3842-8. PMC: 4102633. DOI: 10.1158/1078-0432.CCR-14-0565. View

Gormley M, Yarmolinsky J, Dudding T, Burrows K, Martin R, Thomas S . Using genetic variants to evaluate the causal effect of cholesterol lowering on head and neck cancer risk: A Mendelian randomization study. PLoS Genet. 2021; 17(4):e1009525. PMC: 8096036. DOI: 10.1371/journal.pgen.1009525. View

Kreimer A, Johansson M, Waterboer T, Kaaks R, Chang-Claude J, Drogen D . Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol. 2013; 31(21):2708-15. PMC: 3709056. DOI: 10.1200/JCO.2012.47.2738. View

. Comprehensive genomic characterization of head and neck squamous cell carcinomas. Nature. 2015; 517(7536):576-82. PMC: 4311405. DOI: 10.1038/nature14129. View

Thakral A, Lee J, Hou T, Hueniken K, Dudding T, Gormley M . Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study. Nat Commun. 2024; 15(1):7835. PMC: 11380676. DOI: 10.1038/s41467-024-51679-x. View

10.

Stransky N, Egloff A, Tward A, Kostic A, Cibulskis K, Sivachenko A . The mutational landscape of head and neck squamous cell carcinoma. Science. 2011; 333(6046):1157-60. PMC: 3415217. DOI: 10.1126/science.1208130. View

11.

Patel N, Jo H, Eberhard D, Yin X, Hayward M, Stein M . Improved Tumor Purity Metrics in Next-generation Sequencing for Clinical Practice: The Integrated Interpretation of Neoplastic Cellularity and Sequencing Results (IINCaSe) Approach. Appl Immunohistochem Mol Morphol. 2018; 27(10):764-772. PMC: 6887630. DOI: 10.1097/PAI.0000000000000684. View

12.

Langmead B, Trapnell C, Pop M, Salzberg S . Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 2009; 10(3):R25. PMC: 2690996. DOI: 10.1186/gb-2009-10-3-r25. View

13.

Dogan S, Xu B, Middha S, Vanderbilt C, Bowman A, Migliacci J . Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx. Int J Cancer. 2019; 145(11):3152-3162. PMC: 7595146. DOI: 10.1002/ijc.32412. View

14.

Fitzmaurice C, Allen C, Barber R, Barregard L, Bhutta Z, Brenner H . Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study. JAMA Oncol. 2016; 3(4):524-548. PMC: 6103527. DOI: 10.1001/jamaoncol.2016.5688. View

15.

Patel N, Michelini V, Snell J, Balu S, Hoyle A, Parker J . Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing. Oncologist. 2017; 23(2):179-185. PMC: 5813753. DOI: 10.1634/theoncologist.2017-0170. View

16.

Davey Smith G, Ebrahim S . 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?. Int J Epidemiol. 2003; 32(1):1-22. DOI: 10.1093/ije/dyg070. View

17.

Waterboer T, Sehr P, Michael K, Franceschi S, Nieland J, Joos T . Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins. Clin Chem. 2005; 51(10):1845-53. DOI: 10.1373/clinchem.2005.052381. View

18.

Gormley M, Dudding T, Kachuri L, Burrows K, Chong A, Martin R . Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization. BMC Med. 2022; 20(1):40. PMC: 8802428. DOI: 10.1186/s12916-022-02233-3. View

19.

Seifert B, ODaniel J, Amin K, Marchuk D, Patel N, Parker J . Germline Analysis from Tumor-Germline Sequencing Dyads to Identify Clinically Actionable Secondary Findings. Clin Cancer Res. 2016; 22(16):4087-4094. PMC: 4987173. DOI: 10.1158/1078-0432.CCR-16-0015. View

20.

Kusters J, Diergaarde B, Ness A, Schim van der Loeff M, Heijne J, Schroeder L . Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sex. Int J Cancer. 2023; 154(2):389-402. PMC: 11552661. DOI: 10.1002/ijc.34710. View